Edition:
United Kingdom

Insider Trading: Poxel SA (POXEL.PA)

POXEL.PA on Paris Stock Exchange

7.04EUR
4:35pm BST
Change (% chg)

€0.07 (+1.00%)
Prev Close
€6.97
Open
€6.98
Day's High
€7.09
Day's Low
€6.95
Volume
26,395
Avg. Vol
139,660
52-wk High
€9.18
52-wk Low
€4.92

All Insider Trades

Institutional Holders

% Shares Owned: 40.30%
# of Holders: 17
Total Shares Held: 10,431,242
3 Mo. Net Change: -702,056
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 6
# Reduced Positions: 5
# Net Buyers: 1

Officers & Directors

Name Age Since Current Position

Pierre Legault

57 2016 Chairman of the Board

Thomas Kuhn

Chief Executive Officer, Director

Anne Renevot

2017 Chief Financial Officer

Noah Beerman

52 Executive Vice President - Business Development, US Operations

Christophe Abert-Engels

Executive Vice President - Clinical Development & Medical Affairs

Jonae Barnes

2016 Senior Vice President, Investor Relations and Public Relations

Sophie Bozec

Senior Vice President Pharmacology

Takashi Kaneko

2018 Senior Vice President Medical, President of Poxel Japan K.K

Sebastien Bolze

Scientific Director - Non Clinical Development

Pascale Fouqueray

Medical Director - Early Development & Translational Medicine

Thierry Hercend

2016 Director

Mohammed Baluch

Independent Director

Pascale Boissel

2015 Independent Director

Janice Bourque

2016 Independent Director

Richard Kender

62 2015 Independent Director

Kumi Sato

2017 Independent Director